Revolutionizing Lung Cancer Treatment: Recent Breakthroughs in Immunotherapy
- 20 March 2024
- book chapter
- Published by Springer Nature
- p. 45-64
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Recent advances in immunotherapy for lung cancerCancer Innovation, 2023
- Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 TrialJournal of Thoracic Oncology, 2022
- Recent Advancements of Nanomedicine in Neurodegenerative Disorders TheranosticsAdvanced Functional Materials, 2020
- Mechanisms of PARP inhibitor sensitivity and resistanceDNA Repair, 2018
- Molecular Testing Turnaround Time in Non–Small-Cell Lung Cancer: Monitoring a Moving TargetClinical Lung Cancer, 2018
- Tumor biomarker testing in non-small-cell lung cancer: A decade of changeLung Cancer, 2018
- Improving the dose–myelotoxicity correlation in radiometabolic therapy of bone metastases with 153Sm-EDTMPEuropean Journal of Nuclear Medicine and Molecular Imaging, 2013
- Deficiency of activated STAT1 in head and neck cancer cells mediates TAP1-dependent escape from cytotoxic T lymphocytesCancer Immunology, Immunotherapy, 2011
- Modulation of the antigen transport machinery TAP by friends and enemiesFEBS Letters, 2005
- Escape of Human Solid Tumors from T–Cell Recognition: Molecular Mechanisms and Functional Significance1999